Discontinuing Infliximab in Benign Crohn’s Disease: A Real-Life Population-Based Cohort Study

Abstract

Journal of clinical gastroenterology is part of the Juniper publishers which is devoted to publish subject-specific articles focused on the needs of individual research communities across all areas of biology and medicine. Background/Aims: The need for maintenance therapy with infliximab after remission in patients with benign Crohn’s disease remains to be studied. Our hypothesis was that patients with benign Crohn’s disease did not need maintenance therapy after induction therapy if remission had been achieved.